Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02264613
Title Safety Study of ALRN-6924 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Aileron Therapeutics
Indications

Advanced Solid Tumor

Therapies

ALRN-6924

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST